Insider · CIK 0001786410
Courtney Wallace
Files at KZR (Kezar Life Sciences, Inc.). First filing -, latest -.
Courtney Wallace files SEC Form 4 as director at KZR (Kezar Life Sciences, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Courtney Wallace has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 1 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 18, 2025 | KZR Kezar Life Sciences, Inc. | AGrant or award Stock Option (right to buy)derivative | +5,000 | $0.00 | $0 | 5,000 | Jun 23, 2025 |
Questions about Courtney Wallace
Answered from the filings on this page, as of the latest one.
Is Courtney Wallace buying or selling?
Courtney Wallace has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Courtney Wallace's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Courtney Wallace has 0.
Where does Courtney Wallace file Form 4?
Courtney Wallace has filed Form 4 at KZR (Kezar Life Sciences, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.